ÌÇÄò²¡£¬ÊÇÒ»ÖÖÂýÐÔ¼²²¡£¬Í¨³£ÓÉÒȵºËØ·ÖÃÚ²»×ã»òÕßϸ°û¶ÔÒȵºËØ·´Ó¦²»×ãÒýÆð£¬µ¼Ö¸ßѪÌÇ¡£ÕâÖÖ¼²²¡·ÖΪÈýÖÖÖ÷ÒªÀàÐÍ£º1ÐÍ¡¢2ÐͺÍÈÑÉïÌÇÄò²¡¡£ÌÇÄò²¡µÄ²¡Òòͨ³£ÓëÒÅ´«¡¢»·¾³ÒòËØÏà¹Ø£¬°üÀ¨ÒȵºÏ¸°û¹¦ÄÜÕϰ¡¢ÒȵºËØÃô¸ÐÐÔϽµ£¬»òÁ½Õ߼汸£¬µ¼Ö»úÌåÎÞ·¨ÓÐЧÀûÓúʹ¢´æÑªÌÇ¡£ÓÐЩÌÇÓÑ»¹´æÔÚ¼Ò×åÒÅ´«ÇãÏò¡£¸ù¾Ý×îÐÂÊý¾ÝÏÔʾ£¬ÎÒ¹úÌÇÄò²¡»¼²¡ÂÊÒÑ´ï12.8%£¬ÎÒ¹úÓг¬1.4ÒÚÈË»¼ÌÇÄò²¡¡£2024Äê4ÔÂ30ÈÕ£¬º£¾ü¾üÒ½´óѧµÚ¶þ¸½ÊôÒ½Ôº£¨ÉϺ£³¤Õ÷Ò½Ôº£©ÒóºÆ½ÌÊÚÍŶÓÓëÖйú¿ÆÑ§Ôº·Ö×Óϸ°û¿ÆÑ§×¿Ô½´´ÐÂÖÐÐijÌнÌÊÚÍŶÓÔÚҽѧ¶¥¿¯Cell Discovery¡¶Ï¸°û·¢ÏÖ¡·ÔÚÏß·¢±íÁËÒ»ÏîÖØÒªÑо¿³É¹û£ºÀûÓøöÐÔ»¯µÄÄÚÅß²ã¸Éϸ°ûÀ´Ô´µÄÒȵº×éÖ¯£¬ÖÎÁÆ»¼ÓÐÒȵº¹¦ÄÜÊÜËðµÄ2ÐÍÌÇÄò²¡»¼Õß¡±£¨Treating a type 2 diabetic patient with impaired pancreatic islet function by personalized endoderm stem cell-derived islet tissue£©¡£Õâ¸öÑо¿¿ÉÀ´Í·²»Ð¡£¡Ê×´ÎÔÚ¹ú¼ÊÉϳɹ¦±¨µÀÁËÀûÓøÉϸ°ûÀ´Ô´µÄ×ÔÌåÔÙÉúÒȵºÒÆÖ²£¬ÖÎÓúÁËÒȵº¹¦ÄÜÑÏÖØÊÜËðµÄÌÇÄò²¡»¼Õß¡£ÕâÏî¼¼ÊõµÄÍ»ÆÆ¿ÉÒÔ˵ΪÌÇÄò²¡ÖÎÁÆÁìÓò´øÀ´ÐµÄÏ£Íû£¡À´Ô´£ºhttps://doi.org/10.1038/s41421-024-00662-3Ñо¿ÈËÔ±ÀûÓû¼ÕßѪҺPBMCÖØ±à³ÌΪ×ÔÌåiPSCϸ°û£¬²¢Ê¹Óùú¼ÊÊ×´´¼¼Êõʹ֮ת±äΪ¡°ÖÖ×Óϸ°û¡±¼´ÄÚÅß²ã¸Éϸ°û£¨Endoderm stem cell£¬EnSC£©ÅàÓý³öÁËÌåÍâÔÙÔìÒȵº×éÖ¯£¨E-islet£©£¬È»ºó½«ÕâЩÌåÍâÔÙÔìÒȵº×éÖ¯ÒÆÖ²µ½ÁË»¼ÓÐ2ÐÍÌÇÄò²¡ÇÒÒȵº¹¦ÄÜÊÜËðµÄ»¼ÕßÉíÉÏ[¸Ã»¼ÕßΪ2ÐÍÌÇÄò²¡²¡Ê·³¤´ï25ÄêµÄ59ËêÄÐÐÔ£¬²¢·¢Õ¹ÎªÖÕÄ©ÆÚÌÇÄò²¡Éö²¡£¨Äò¶¾Ö¢£©£¬2017Äê6Ô¸û¼Õß³öÏÖÖÕÄ©ÆÚÌÇÄò²¡Éö²¡²¢½ÓÊÜÉöÒÆÖ²¡£µ«ÓÉÓÚÆäÒȵº¹¦Äܼ¸ºõË¥½ß£¬»¼ÕßÐèÿÈÕ¶à´Î×¢ÉäÒȵºËØ£¬´æÔÚ¼«´óµÄÌÇÄò²¡ÑÏÖØ²¢·¢Ö¢·çÏÕ£¡]ÒÆÖ²ºó£¬»¼ÕßµÄѪÌÇ¿ØÖƵõ½ÁËÏÔÖø¸ÄÉÆ£¬¶øÇÒûÓгöÏÖÖ×ÁöÐγɵÈÑÏÖØ¸±×÷Óá£×ÔÌåÒȵºÒÆÖ²ÖÎÁÆ2ÐÍÌÇÄò²¡µÄ¼òÒªÁ÷³Ì¾ßÌåÀ´Ëµ£¬»¼Õß½ÓÊÜE-ÒȵºÒÆÖ²ºó£¬ÑªÌÇ¿ØÖÆÖ𽥸ÄÉÆ¡£Í¨¹ý¶¯Ì¬ÑªÌÇÒǼà²âÏÔʾ£¬ÑϸñѪÌÇÄ¿±ê·¶Î§ÄÚʱ¼ä£¨TITR£©´ÓÊõǰµÄ57%Öð½¥ÉÏÉýµ½32ÖÜʱ»Ö¸´µ½99%ÒÔÉÏ£¨TITRÖµÔ½¸ßÔ½ºÃ£©¡£ÑÏÖØ¸ßѪÌÇ£¨> 13.9 mmol/L£©ºÍÑÏÖØµÍѪÌÇ£¨<3.9 mmol/L£©ÔÚÊõºóÁ½ÖÜÄÚÍêÈ«Ïûʧ¡£²Íǰ²ÍºóµÄѪÌDZäÒì¶È´ÓÊõǰµÄ5.50 mmol/L Ͻµµ½32ÖÜµÄ 1.6 mmol/L¡£Ñо¿ÈËÔ±±íʾ£¬»¼ÕߵĹؼüÖ¸±êÈç¿Õ¸¹¼°²ÍºóCëÄÃ÷ÏÔÌá¸ß£¬ÓÉ´ËÒ²¿ÉÖ¤Ã÷Òȵº¹¦ÄÜÓÐЧ»Ö¸´¡£Ëæ·ÃÏÔʾ£¬»¼ÕßÉöÔ๦ÄÜÕý³££¬ÒÆÖ²ÎïÄÍÊÜÐÔÁ¼ºÃ£¬ÎÞÖ×ÁöÐγɻòÑÏÖØ²»Á¼Ê¼þ¡£ÕâÊÇÊ×´ÎʹÓÃ×ÔÌåÑÜÉúÒȵºÖÎÁÆ2ÐÍÌÇÄò²¡»¼ÕßµÄÈËÌå×éÖ¯Ìæ´úÁÆ·¨¡£Î´À´Ñо¿ÍŶӽ«¾Û½¹¸Éϸ°ûÀ´Ô´ÔÙÉúÒȵº×éÖ¯µÄÏà¹ØÑо¿£¬½øÒ»²½¿ª·¢ÎÞÐèÃâÒßÒÖÖÆµÄ¡°Í¨ÓÃÐÍ¡±ÔÙÉúÒȵº×éÖ¯£¬´Ó¶øÎª¹ã´ó³¤ÆÚÒÀÀµÒȵºËØ×¢ÉäµÄÌÇÄò²¡»¼ÕßÌṩеÄÖÎÓúÁÆ·¨¡£
²Î¿¼ÎÄÏ×
[1]Wu£¬ J.£¬ Li£¬ T.£¬ Guo£¬ M. et al. Treating a type 2 diabetic patient with impaired pancreatic islet function by personalized endoderm stem cell-derived islet tissue. Cell Discov 10£¬ 45 £¨2024£©.https://doi.org/10.1038/s41421-024-00662-3
